Mark D Huffman

Datos Biográficos

ID127054
NOMBREMark D Huffman
NOMBRESMark D
APELLIDOHuffman
FIRMAHUFFMAN M D
AFILIACIONESWashington University in St. Louis
ORCID0000-0001-7412-2519
VERIFICADOSí
TOTAL DE OBRAS19
TOTAL DE CITAS0
TOTAL COMO AUTOR19
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2011
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Advancing public health leadership through culturally centered and responsive research mentorship training in Nigeria

    Open AccessRifkatu Reng, Manmak Mamven et al.ARTICLEFrontiers in Public Health2025

    Effective leadership in research and public health is critical to strengthen evidence generation and translation into policy and practice. Mentorship in research and public health is critical to develop leaders, but mentorship training is often ad hoc and may not be effective, particularly when it does not reflect local cultural and academic contextual realities. The Cardiovascular Research Training in Nigeria (CeRTIN) program, a funded partnersh…

  • Trust, trust repair, and public health

    Open AccessPeter Kalulu, Aubrey Fisher et al.ARTICLEFrontiers in Public Health2025

    Objective This study investigates the scope of evidence on trust, trust repair, and public health. Methods We identified quantitative studies that evaluated the relationship between trust or trust repair and public health from January 1990 to May 2023. Results were stratified evaluating trust as an exposure or outcome and reporting on trust repair. Data are reported on spatiotemporal trends in publications, level of trust (institutional trust, ge…

  • Design and implementation of a drug revolving fund for hypertension treatment in primary care setting of the Federal Capital Territory, Nigeria

    Open AccessGrace Julcit Shedul, Eugenia N Ugwuneji et al.ARTICLEBMJ Global Health2025

    BACKGROUND: Expanding treatment for hypertension requires ensuring access to affordable, high-quality blood pressure (BP) lowering medications. We describe the design, implementation and evaluation of a BP-lowering medication drug revolving fund (DRF) embedded in the Hypertension Treatment in Nigeria (HTN) Programme in 60 primary healthcare centres (PHCs) in the Federal Capital Territory, Nigeria. METHODS: We used the exploration, preparation, im…

  • Does health insurance coverage improve cardiometabolic risk factor levels? Quasi-experimental evidence from India

    Open AccessKavita Singh, Dimple Kondal et al.ARTICLEGlobal Health Action2025

    Background Chronic conditions cause notable health and economic burdens. While health insurance enables access to healthcare, its effects on chronic care outcomes remain under-explored.Objective To examine the association between health insurance coverage and cardiometabolic risk factors among people with chronic conditions in India.Methods Data from the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) and Solan studies, including …

  • Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans - fatty acids in Nigeria

    Open AccessMatti Marklund, Léopold Ndemnge Aminde et al.ARTICLEBMJ Global Health2024

    Introduction Nigeria is committed to reducing industrial trans- fatty acids (iTFA) from the food supply, but the potential health gains, costs and cost-effectiveness are unknown. Methods The effect on ischaemic heart disease (IHD) burden, costs and cost-effectiveness of a mandatory iTFA limit (≤2% of all fats) for foods in Nigeria were estimated using Markov cohort models. Data on demographics, IHD epidemiology and trans- fatty acid intake were d…

  • Nigeria healthcare worker Sars-CoV-2 serology study

    Open AccessDike Ojji, Amelia Sancilio et al.ARTICLEPLOS Global Public Health2023

    Healthcare workers, both globally and in Nigeria, have an increased risk for SARS-CoV-2 infection compared with the general population due to higher risk contacts, including occupational exposures. In addition, primary healthcare workers represent an important group for estimating prior infection to SARS-CoV-2 because they work at the first point-of-contact for most patients yet have not been included in prior COVID-19 seroepidemiology research i…

  • Association between incarceration and incident cardiovascular disease events

    Open AccessJordan Coleman, Donald M Lloyd-Jones et al.ARTICLEBMC Public Health2021

    Incarceration was associated with incident cardiovascular disease rates, but associations were only significant in one sex-race group after multivariable adjustment

  • Using implementation science to mitigate worsening health inequities in the United States during the Covid-19 pandemic

    Open AccessTyler Jacobson, Tyler A Jacobson et al.ARTICLEInternational Journal for Equity…2020

    With the threat of coronavirus disease 2019 (Covid-19) enduring in the United States, effectively and equitably implementing testing, tracing, and self-isolation as key prevention and detection strategies remain critical to safely re-opening communities. As testing and tracing capacities increase, frameworks are needed to inform design and delivery to ensure their effective implementation and equitable distribution, and to strengthen community en…

  • Evaluating Longitudinal Associations Between Depressive Symptoms, Smoking, and Biomarkers of Cardiovascular Disease in the Cardia Study

    Allison J Carroll, Mark D Huffman et al.ARTICLEPsychosomatic Medicine2019

    OBJECTIVE: The aim of the study was to evaluate associations between 15-year trajectories of co-occurring depressive symptoms and smoking with biomarkers of cardiovascular disease at year 15. METHODS: In the Coronary Artery Risk Development in Young Adults study, we modeled trajectories of depressive symptoms (Center for Epidemiologic Studies-Depression scale [CES-D]) and smoking (cigarettes per day [CPD]) among 3614 adults followed from year 0 (…

  • Efficacy of a group tobacco cessation behavioral intervention among tobacco users with concomitant mental illness in Kenya

    Open AccessYvonne Olando, Mary Wangari Kuria et al.ARTICLEBMC Public Health2019

    Trial registration number: NCT04013724. Name of registry: ClinicalTrials.gov. URL of registry: https://register.clinicaltrials.gov Date of registration: 9 July 2019 (retrospectively registered). Date of enrolment of the first participant to the trial: 5th September 2017. Protocol version: 2.0

  • Tobacco Cessation Among Acute Coronary Syndrome Patients in Kerala, India

    Open AccessSmitha S Bhaumik, Caitlyn D Placek et al.ARTICLEQualitative Health Research2019Referencias: 27

    Tobacco cessation is an important intervention to reduce mortality from ischemic heart disease, the leading cause of death in India. In this study, we explored facilitators, barriers, and cultural context to tobacco cessation among acute coronary syndrome (ACS, or heart attack) patients and providers in a tertiary care institution in the south Indian state of Kerala, with a focus on patient trajectories. Patients who quit tobacco after ACS expres…

  • Implementation of 100% smoke-free law in Uganda

    Open AccessLindsay Robertson, Kellen Namusisi Nyamurungi et al.ARTICLEBMC Public Health2018

    This study suggests that the process of smoke-free law implementation in Uganda has not aligned with World Health Organisation (WHO) guidelines for implementing smoke-free laws, and highlights that low-income countries may need additional support to enable them to effectively plan for policy implementation and resist industry interference

  • Differences in the sodium content of bread products in the USA and UK

    Open AccessKasey J Coyne, Abigail S Baldridge et al.ARTICLEPublic Health Nutrition2018

    Objective Americans consume Na in excess of daily recommendations. Most dietary Na comes from packaged foods, and bread is a major contributor. In the UK, national Na reduction strategies contributed to lower Na levels in packaged foods and lower population Na intake. Similar initiatives are emerging in the USA and require surveillance to assess effectiveness. We aimed to examine Na levels in bread products in the USA and compare levels with simi…

  • Heart Disease and Stroke Statistics—2016 Update

    Dariush Mozaffarian, Emelia J Benjamin et al.ARTICLECirculation2016

    Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together the most up-to-date statistics related to heart disease, stroke, and other cardiovascular and metabolic diseases and presents them in its Heart Disease and Stroke Statistical Update. The Statistical Update represents a critical resource for the lay pu…

  • Heart Disease and Stroke Statistics—2015 Update

    Dariush Mozaffarian, Emelia J Benjamin et al.ARTICLECirculation2015

    Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together the most up-to-date statistics related to heart disease, stroke, and other cardiovascular and metabolic diseases and presents them in its Heart Disease and Stroke Statistical Update. The Statistical Update represents a critical resource for the lay pu…

  • Heart Disease and Stroke Statistics—2014 Update

    Alan S Go, Dariush Mozaffarian et al.ARTICLECirculation2014

    Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together the most up-to-date statistics on heart disease, stroke, other vascular diseases, and their risk factors and presents them in its Heart Disease and Stroke Statistical Update. The Statistical Update is a critical resource for researchers, clinicians, h…

  • Heart Disease and Stroke Statistics—2013 Update

    Alan S Go, Dariush Mozaffarian et al.ARTICLECirculation2013

    Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together the most up-to-date statistics on heart disease, stroke, other vascular diseases, and their risk factors and presents them in its Heart Disease and Stroke Statistical Update*The Statistical Update is a valuable resource for researchers, clinicians, he…

  • P2-128 Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian sentinel surveillance study population

    Panniyammakal Jeemon, Dorairaj Prabhakaran et al.ARTICLEJournal of Epidemiology and…2011

    Introduction Cardiovascular disease (CVD) prevention guidelines recommend lifetime risk stratification for primary prevention of CVD, but no such risk stratification has been performed in India to date. Methods We estimated short-term and lifetime predicted CVD risk among 10 054 disease free, adult Indians in the age group of 20-69 years who participated in a nationwide risk factor surveillance study. The study population was then stratified into…

  • Regarding the Prevention of Global Chronic Disease

    Mark D Huffman, Karen R Siegel et al.ARTICLEAmerican Journal of Public Health2011Referencias: 5

    It was with great interest that we read the recent article “The Prevention of Global Chronic Disease: Academic Public Health's New Frontier” by Greenberg et al.1 As members of the Young Professionals’ Chronic Disease network, we believe that the importance of educating and training the next generation for global chronic disease prevention and control has been largely missing in current calls to action.2 In light of the projected human resource sh…